List of Tables
    Table 1. Peroxisome Proliferator Activated Receptor Delta CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Peroxisome Proliferator Activated Receptor Delta Market Trends
    Table 3. Peroxisome Proliferator Activated Receptor Delta Market Drivers
    Table 4. Peroxisome Proliferator Activated Receptor Delta Market Challenges
    Table 5. Peroxisome Proliferator Activated Receptor Delta Market Restraints
    Table 6. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Peroxisome Proliferator Activated Receptor Delta Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Peroxisome Proliferator Activated Receptor Delta Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Peroxisome Proliferator Activated Receptor Delta Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Peroxisome Proliferator Activated Receptor Delta Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Manufacturer, 2017-2022
    Table 15. Global Peroxisome Proliferator Activated Receptor Delta Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Peroxisome Proliferator Activated Receptor Delta Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Peroxisome Proliferator Activated Receptor Delta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2021)
    Table 18. Top Players of Peroxisome Proliferator Activated Receptor Delta in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Peroxisome Proliferator Activated Receptor Delta Product Type
    Table 20. Date of International Manufacturers Enter into Peroxisome Proliferator Activated Receptor Delta Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Peroxisome Proliferator Activated Receptor Delta Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Peroxisome Proliferator Activated Receptor Delta Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Peroxisome Proliferator Activated Receptor Delta Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Peroxisome Proliferator Activated Receptor Delta Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Peroxisome Proliferator Activated Receptor Delta Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Peroxisome Proliferator Activated Receptor Delta Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Peroxisome Proliferator Activated Receptor Delta Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Chipscreen Biosciences Ltd Corporation Information
    Table 43. Chipscreen Biosciences Ltd Description and Business Overview
    Table 44. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product
    Table 46. Chipscreen Biosciences Ltd Recent Development
    Table 47. Connexios Life Sciences Pvt Ltd Corporation Information
    Table 48. Connexios Life Sciences Pvt Ltd Description and Business Overview
    Table 49. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Connexios Life Sciences Pvt Ltd Product
    Table 51. Connexios Life Sciences Pvt Ltd Recent Development
    Table 52. CymaBay Therapeutics Inc Corporation Information
    Table 53. CymaBay Therapeutics Inc Description and Business Overview
    Table 54. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. CymaBay Therapeutics Inc Product
    Table 56. CymaBay Therapeutics Inc Recent Development
    Table 57. Genfit SA Corporation Information
    Table 58. Genfit SA Description and Business Overview
    Table 59. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Genfit SA Product
    Table 61. Genfit SA Recent Development
    Table 62. Inventiva Corporation Information
    Table 63. Inventiva Description and Business Overview
    Table 64. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Inventiva Product
    Table 66. Inventiva Recent Development
    Table 67. Mitobridge Inc Corporation Information
    Table 68. Mitobridge Inc Description and Business Overview
    Table 69. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Mitobridge Inc Product
    Table 71. Mitobridge Inc Recent Development
    Table 72. Nippon Chemiphar Co Ltd Corporation Information
    Table 73. Nippon Chemiphar Co Ltd Description and Business Overview
    Table 74. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Nippon Chemiphar Co Ltd Product
    Table 76. Nippon Chemiphar Co Ltd Recent Development
    Table 77. Senju Pharmaceutical Co Ltd Corporation Information
    Table 78. Senju Pharmaceutical Co Ltd Description and Business Overview
    Table 79. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Senju Pharmaceutical Co Ltd Product
    Table 81. Senju Pharmaceutical Co Ltd Recent Development
    Table 82. T3D Therapeutics Inc Corporation Information
    Table 83. T3D Therapeutics Inc Description and Business Overview
    Table 84. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. T3D Therapeutics Inc Product
    Table 86. T3D Therapeutics Inc Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Peroxisome Proliferator Activated Receptor Delta Customers List
    Table 90. Peroxisome Proliferator Activated Receptor Delta Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Peroxisome Proliferator Activated Receptor Delta Product Picture
    Figure 2. Global Peroxisome Proliferator Activated Receptor Delta Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Peroxisome Proliferator Activated Receptor Delta Market Size 2017-2028 (US$ Million)
    Figure 4. Global Peroxisome Proliferator Activated Receptor Delta Sales 2017-2028 (K Pcs)
    Figure 5. United States Peroxisome Proliferator Activated Receptor Delta Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Peroxisome Proliferator Activated Receptor Delta Market Size 2017-2028 (US$ Million)
    Figure 7. United States Peroxisome Proliferator Activated Receptor Delta Sales 2017-2028 (K Pcs)
    Figure 8. United States Peroxisome Proliferator Activated Receptor Delta Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Peroxisome Proliferator Activated Receptor Delta Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Peroxisome Proliferator Activated Receptor Delta Report Years Considered
    Figure 11. Product Picture of MTB-2
    Figure 12. Product Picture of HPP-593
    Figure 13. Product Picture of CNX-013B2
    Figure 14. Product Picture of CS-038
    Figure 15. Product Picture of MA-0204
    Figure 16. Product Picture of Others
    Figure 17. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Type in 2022 & 2028
    Figure 18. Global Peroxisome Proliferator Activated Receptor Delta Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Peroxisome Proliferator Activated Receptor Delta Market Share by Type in 2022 & 2028
    Figure 24. United States Peroxisome Proliferator Activated Receptor Delta Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Peroxisome Proliferator Activated Receptor Delta Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Peroxisome Proliferator Activated Receptor Delta Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Bone Disorders
    Figure 30. Product Picture of Colitis
    Figure 31. Product Picture of Obesity
    Figure 32. Product Picture of Osteoporosis
    Figure 33. Product Picture of Others
    Figure 34. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Application in 2022 & 2028
    Figure 35. Global Peroxisome Proliferator Activated Receptor Delta Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application (2017-2028)
    Figure 37. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028) & (K Pcs)
    Figure 38. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application (2017-2028)
    Figure 39. Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. United States Peroxisome Proliferator Activated Receptor Delta Market Share by Application in 2022 & 2028
    Figure 41. United States Peroxisome Proliferator Activated Receptor Delta Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 42. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application (2017-2028)
    Figure 43. United States Peroxisome Proliferator Activated Receptor Delta Sales by Application (2017-2028) & (K Pcs)
    Figure 44. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application (2017-2028)
    Figure 45. United States Peroxisome Proliferator Activated Receptor Delta Price by Application (2017-2028) & (USD/Pcs)
    Figure 46. North America Peroxisome Proliferator Activated Receptor Delta Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. North America Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. U.S. Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Canada Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Europe Peroxisome Proliferator Activated Receptor Delta Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 51. Europe Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. Germany Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. France Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.K. Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Italy Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Russia Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 58. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 59. China Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Japan Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. South Korea Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. India Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Australia Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Taiwan Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Indonesia Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Thailand Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Malaysia Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Philippines Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Mexico Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Brazil Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Argentina Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 75. Middle East & Africa Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 76. Turkey Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Saudi Arabia Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. U.A.E Peroxisome Proliferator Activated Receptor Delta Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. Peroxisome Proliferator Activated Receptor Delta Value Chain
    Figure 80. Peroxisome Proliferator Activated Receptor Delta Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed